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Purpose: Brain Derived Neurotrophic Factor (BDNF) is part of the superfamily of 
neurotrophins including: nerve growth factor (NGF), neurotrophin-3 (NT-3) and 
neurotrophin-4 (NT-4). Recent evidence suggests that aerobic activity can increase 
BDNF levels both during and following exercise. Likewise, dietary habits have been 
shown to alter BDNF levels. However, nothing is known about the effect of BDNF levels 
during aerobic activity under specific dietary interventions. The purpose of this study 
was to examine the effects of specific macronutrient supplementation on BDNF levels 
during aerobic exercise. Methods: We had the opportunity to determine BDNF levels in 
blood samples obtained from two separate projects whereby subjects completed 2 
hours of cycling. Specifically, 14 endurance-trained cyclists (VO2 max : 62 ± 7 ml/kg/min) 
from two previous studies: Study A focused on protein (PRO) and placebo (PLA) 
supplementation (6 subjects: 3 males and 3 females) and Study B focused on 
carbohydrate (CHO) supplementation (8 subjects: 6 males and 2 females) during 
constant load cycling. Both studies had nearly identical exercise protocols of constant 
load cycling for 120 minutes at 50% (CHO) and 55% (PLA/PRO) of peak power at VO2 
max. In both studies blood samples were obtained prior to exercise and immediately 
following the 120-minute ride, allowing us to make preliminary comparisons between 
studies. Upon the start and every 15 minutes during steady state cycling, subjects were 
given a PLA, PRO, or CHO drink. Serum BDNF concentration both before and after the 
two-hour fixed intensity trial were analyzed with standard ELISA (enzyme-linked 
immunosorbent assay) methodology. The following comparisons were made: PRO vs. 
PLA (Study A) and CHO (Study B) vs. PLA (Study A). Results: BDNF levels ‘almost 
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certainly’ increased (24 ± 10%) following 120 minutes of cycling with PLA. Similarly, 
BDNF levels were ‘very likely’ elevated (32 ± 32%) following 120 minutes of cycling with 
PRO. All 6 subjects experienced an increase in BDNF levels under the PLA condition, 
while 4 out of 6 subjects increased BDNF levels with PRO. Conversely, the change in 
BDNF levels was ‘unclear’ (2 ± 17%) following 120 minutes of cycling with CHO. There 
was an ‘unclear’ difference between the PLA vs. PRO trials, while the PLA vs. CHO 
trials conveyed a ‘likely’ difference in post-exercise BDNF response. Conclusion: 
BDNF levels were elevated in PLA and PRO treatments, while the CHO treatment had 
unclear effects. PLA data confirms elevated BDNF response due to aerobic exercise, 
while PRO data suggests a similar response. BDNF response seemed to be blunted by 
CHO treatment. The results from this project justify follow-up investigations to determine 




























Brain-derived neurotrophic factor (BDNF) was first discovered during the 
purification of pig brain matter by Barde and colleagues in 1982 (Barde et al, 1982). 
BDNF is one of four known neurotrophin growth factors, the others being nerve growth 
factor (NGF), neurotrophin-3 (NT-3) and neurotrophin-4 (NT-4) (Bath and Lee, 2006). 
The primary functions of BDNF are to promote neuron survival, plasticity, and 
maturation (Numakawa et al, 2010). BDNF functions to promote the survival of 
damaged neurons in those who, for example, have Parkinson’s disease or who have 
suffered a blow to the head. Otherwise, healthy neurons are able to survive a human 
lifetime (Barde et al, 1993). Neuroplasticity is a prevalent function of BDNF where 
neurons are able to adapt to developmental and environmental influences as well as 
from disease and injury (World Health Organization, 1983). BDNF is also able promote 
the maturation of neurons and the maintenance of mature neurons (Numakawa et al, 
2010). Since BDNF is active in the hippocampus, cortex, and cerebellum, it has a strong 
effect on higher order processes, such as learning and memory, especially later in life 
(Bath and Lee, 2006; Huang & Reichardt, 2001). Ostensibly, an abundance of BDNF 
would be physiologically advantageous. 
One strategy to enhance BDNF levels is physical activity/exercise. Both acute 
strength and endurance training result in transient increases in BDNF during exercise 
(Correia et al, 2010; Gold et al, 2003, Seifert et al, 2010). Chronic resistance training 
yields the same results. Five weeks of strength training can robustly increase serum 
BDNF levels, although BDNF returned to resting levels within 30 minutes of exercise 
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completion in both pre and post-training intervention (Yarrow et al, 2010). Endurance 
exercises, such as running and cycling, have conveyed similar results. Five weeks of 
endurance training can elevate basal plasma BDNF levels (3-fold higher) (Zoladz, 
2008). Additionally, chronic aerobic exercise can elicit high BDNF levels under resting 
conditions (Zoladz et al, 2008). Exercise intensity also appears to be associated with 
the magnitude of BDNF production. As intensity increases so does the rate at which 
BDNF levels increase (Griffin et al, 2011). During aerobic exercise BDNF is synthesized 
and secreted by sympathetic and sensory target organs (Huang & Reichardt, 2001). 
BDNF then travels in the blood to the brain, primarily to the hippocampus and cerebral 
cortex, and to working muscle. BDNF has also been proven to be produced in skeletal 
muscle cells, where it only acts locally and is not released into the blood stream (Wrann 
et al, 2010; Matthews et al, 2009). Elevated BDNF levels in the brain can lead to an 
increased hippocampus size, which has been linked to neurological health by a study 
that examined the positive correlation between brain size and endurance exercise 
capacity (Raichlen & Gordon, 2011). 
In addition to exercise, nutrition can affect BDNF levels. Both high fat and high 
carbohydrate diets have been linked to decreased BDNF levels (Molteni et al, 2004; 
Maioli et al, 2012). On the other hand, caloric restriction and reduced meal frequency 
can increase BDNF and improve brain function (Mattson & Wan, 2005). Certain foods 
and diets can also positively impact BDNF. For example, blueberries have been shown 
to improve brain function, in aged rats, by increasing BDNF levels (Williams et al, 2008). 
Also, a Mediterranean diet, with an emphasis on nuts, has been linked to increased 
BDNF levels in those with prevalent depression (Sanchez-Villegas et al, 2011). Though 
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the impact of daily nutritional habits on BDNF levels have been examined, the potential 
effects of nutrition during exercise on the BDNF response has not been examined.  
The purpose of this investigation was to explore the effects of macronutrient 
supplementation during exercise on BDNF. Specifically, we had the opportunity to 
assay blood samples obtained before and after 2 hours of cycling exercise performed 
with carbohydrate (CHO) feedings, protein (PRO) feedings, and water (PLA) (Schroer et 
al, 2014; ‘unpublished observations’). A possible link between nutrient intake during 
exercise and increased BDNF levels could have implications for maximizing BDNF 
production in order to promote higher levels of brain function as well as neuron survival 



















BDNF levels were determined in blood samples collected from two previous 
studies that examined the effects of PRO (Schroer et al, 2014) and CHO 
supplementation (Luden et al, 2014) on cycling performance. Both studies implemented 
virtually identical exercise trials with subjects that possessed a VO2max ≥ 50 ml/kg/min or 
4.0 L/min. Additionally, subjects in the CHO study completed ≥ 7 hours of cycle training 
each week for ≥ 2 months preceding participation in the study, while no specific training 
duration requirements were implemented in the PRO study. Performance trials 
commenced with 120 minutes of constant load cycling, during which subjects received 
either placebo or treatment beverages that contained macronutrients (CHO or PRO).  
In both studies blood samples were obtained prior to exercise and immediately 
following the 120-minute ride, allowing us to make preliminary comparisons between 
studies. As seen in Table 3.1, Study A included 6 college-aged (3 males and 3 females) 
endurance-trained cyclists who completed 4 exercise trials (one being a familiarization 
trial where only water was consumed) that each consisted of 120 minutes of constant 
load cycling at 55% of peak power at VO2max. Treatments were artificially sweetened 
placebo (Splenda) and 45 g/L whey protein hydrolysate (purchased from American 
Casein Company). Each solution also contained 470 mg/L sodium chloride, 200-mg/L 
potassium chloride, and 4.1 g/L artificial vanilla flavoring (Bakers Imitation Vanilla). 
Treatment beverages were provided immediately prior to the beginning of exercise and 
every 15 minutes throughout the constant load cycling (Schroer et al, 2014).  
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As seen in Table 3.1, Study B included 8 college-aged (6 males and 2 females) 
endurance-trained cyclists who completed a large-scale study designed to examine the 
impact of PRO supplementation on physiological responses to 10 days of heavy cycling 
and 10 days of recovery. Similar to study A, subjects performed constant load trials 
consisting of 120 min at 50% of peak power. The exercise that marked the beginning of 
the heavy training phase was used for this project, where subjects consumed 45 g of 
CHO per hour (Gatorade with 6% carbohydrate) (Luden et al, 2014). This study 
provided no placebo trial for comparison. Therefore, the following comparisons were 
made: PRO vs. PLA (Study A) and CHO (Study B) vs. PLA (Study A). 
Serum BDNF 
 Study A collected 3 ml blood samples from an antecubital vein before exercise 
and following the two-hour constant load trial. After 30 minutes of clotting, samples were 
centrifuged at 3,000 rpm for 10 minutes then stored at -80oC for later analysis (Schroer 
et al, 2014). Study B collected 10 ml blood samples from an antecubital vein before 
exercise and following the two-hour constant load trial. After 30 minutes of coagulation, 
samples were centrifuged at 10,000 rpm and later stored at -80oC for later analysis 
(Luden et al, 2014). Serum BDNF concentration both before and after the two-hour 
constant load trial were analyzed with standard ELISA (enzyme-linked immunosorbent 
assay) methodology.  
Statistical Analysis 
Data were log transformed to diminish the effects of nonuniformity. Magnitude-
based inferences about the data were derived using methods described by Hopkins and 
colleagues (Hopkins et al., 2009). The ‘smallest worthwhile change’ in BDNF was 
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calculated and used as the threshold value for a substantial treatment effect (i.e. 
change in BDNF with CHO vs. change in BDNF with PLA) (Hopkins, 2004). The 
smallest worthwhile change in BDNF was defined as 0.2 x the between subject 
variability in the change in BDNF with exercise under placebo conditions (artificially 
sweetened non-caloric beverage). 
Published spreadsheets (Hopkins, 2006a and b) were then used to determine the 
likelihood of the true treatment effect (of the population) reaching the substantial change 
threshold (above); these percent likelihoods were classified as: <1% almost certainly no 
chance, 1-5% = very unlikely, 5-25% = unlikely, 25-75% = possible, 75-95% = likely, 95-
99% = very likely, and >99% = almost certain. Mechanistic inference criteria was used 
to classify the effects of treatment on the BDNF response. Specifically, if the percent 
chance of the effect reaching the substantial change threshold was <25% and the effect 
was clear, it was classified as ‘trivial’. The effect was classified as unclear if 90% 
confidence intervals included values that exceeded the substantial change threshold for 
both a positive and negative effect; effects were classified as unclear (>5% chance of 





 Subject demographics are displayed in Table 3.1. BDNF levels before and after 
exercise are displayed in Table 3.2 and Figure 3.1. Data reported parenthetically are the 
mean effect ± 90% Confidence Interval. BDNF levels were ‘almost certainly’ increased 
(24 ± 10%) immediately following 2 hours of cycling with PLA. Similarly, BDNF levels 
were ‘very likely’ higher (32 ± 32%) following 2 hours of cycling with PRO. All 6 subjects 
experienced an increase in BDNF levels under the PLA condition, while 4 out of 6 
subjects increased BDNF levels with PRO. Conversely, the change in BDNF levels was 
‘unclear’ (2 ± 17%) following 2 hours of cycling with CHO. There was an ‘unclear’ 
difference between the PLA vs. PRO trials, while the PLA vs. CHO trials conveyed a 
















The primary objective of this project was to provide insight into the possibility that 
nutritional intake during aerobic exercise could influence the BDNF response to 
exercise. As anticipated, BDNF levels increased under PLA conditions. PRO intake 
during exercise did not appear to influence this response. Interestingly, BDNF did not 
increase with CHO intake in a separate group of subjects. However, the lack of a BDNF 
response with CHO may have been influenced by factors unrelated to the CHO 
supplementation. Specifically, the subject group that received the CHO treatment 
exhibited higher baseline BDNF values than the PLA/PRO group and a higher training 
status.  
The PLA group experienced an ‘almost certain’ increase in BDNF following 2 
hours of fixed intensity cycling with both PLA and PRO. This result is consistent with a 
growing body of literature that indicates BDNF concentrations increase as a result of 
acute endurance exercise (Gold et al, 2003). Studies show that acute endurance 
exercise can increase BDNF mRNA and its tyrosine kinase receptor, TrkB (Kim et al, 
2005). Specifically, during exercise an action potential is sent down a motor nerve to 
release the neurotransmitter, glutamate. Once glutamate binds to post-synaptic 
receptors, AMPA and NMDA, the post-synaptic nerve depolarization opens up voltage-
gated calcium channels. The influx of calcium stimulates exocytosis of storage vesicles 
containing neurotrophins (i.e. BDNF). Once BDNF is released it binds to its TrkB 
receptor and stimulates calcium secretion from intracellular stores causing a continuous 
BDNF release from a single nerve cell (Lessman et al, 2003). With enhanced 
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transcription due to increased mRNA of BDNF and TrkB this process is able to occur at 
a faster rate, therefore increasing BDNF levels. Furthermore, this process seems to be 
more prevalent 24 hours after exercise, meaning increased BDNF levels immediately 
following exercise are not due to enhanced transcription (Yarrow et al, 2010). Instead, 
the immediate increases in BDNF may be facilitated by platelet activation (Matthews et 
al, 2009). Platelets are known to store and release BDNF (Fujimora et al, 2002). In a 
study conducted by Matthews et al, the pattern of increased platelet count after a 2-hour 
fixed intensity cycle bout nearly matched that of serum BDNF. Furthermore, plasma 
levels of P-selectin, a marker of platelet activation, were also increased immediately 
following exercise (Matthews et al, 2009). Additionally, with PRO supplementation 
during the 2-hour fixed intensity cycle, there was a ‘very likely’ increase in BDNF levels. 
Compared to the results of the PLA group, there was an ‘unclear’ difference between 
the two treatments. To our knowledge, these are the first data gathered on the impact of 
PRO during exercise on BDNF levels and PRO supplementation did not seem to effect 
BDNF levels in a positive or negative way. 
We also had the opportunity to assess the BDNF response to a virtually identical 
exercise session in a separate group of subjects that received CHO supplementation. 
Interestingly, in contrast to the clear increase in BDNF with PLA and PRO in the 
aforementioned subjects, there was an ‘unclear’ change in BDNF levels following 
exercise, suggesting that CHO availability may mediate the BDNF response to exercise. 
Although BDNF is generally thought to be produced by- and concentrated in- the brain 
(Barde et al, 1982), BDNF can also be produced in skeletal muscle cells. BDNF 
produced by skeletal muscle cells is not released into circulation and only acts locally 
	
17 
(Matthews et al, 2009). In this study, Matthews et al treated the extensor digitorum 
longus and tibialis cranialis muscles of a rat with BDNF via electroporation. Introducing 
BDNF vectors into these muscle cells caused increased phosphorylation of AMP-
activated protein kinase (AMPK) and acetyl coenzyme A carboxylase ß (ACCß) as well 
as enhanced fat oxidation in vitro and ex vivo. The increased fat oxidation due to BDNF 
was AMPK-dependent, as the BDNF response was abrogated in cells treated with 
AMPK inhibitors. AMPK is activated via muscle contraction; meaning during the fixed 
intensity cycle AMPK was activated. Ultimately, this study identified BDNF as a 
contraction-inducible protein in skeletal muscle that is capable of increasing fat 
oxidation via activation of AMPK (Matthews et al, 2009). Furthermore, phosphorylation 
of AMPK has been found to decrease in rats exposed to CHO supplementation post-
meal vs. rats exposed to water (placebo) post-meal (Wilson et al, 2011). This possible 
relationship between CHO and AMPK as well as the AMPK and BDNF relationship, may 
partially explain effects of CHO supplementation on BDNF levels. Another possible 
explanation for the effects of CHO supplementation on BDNF levels is the inverse 
relationship represented between BDNF and plasma glucose levels (Krabbe et al, 
2007). Mean plasma glucose levels at 120 minutes in this study were 72, 76, and 87 
mg/dL for PRO, PLA, and CHO, respectively. Glucose levels were much higher in the 
CHO group, which, according to Krabbe et al, would suggest decreased BDNF levels. 
Out of 8 subjects, 5 experienced decreased BDNF levels following the 120-minute trial. 
While a link between CHO availability and BDNF is an intriguing prospective, it is 
important to note that there are a number of confounding factors that make if it difficult 
for us to definitely conclude that the CHO treatment directly impacted the BDNF 
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response. A small difference in training status was present between the two groups with 
an average VO2max: 59.6 ± 4.2 mL/kg/min for the PLA/PRO group and VO2max: 63.2 ± 
8.2 mL/kg/min for the CHO group, which may have effected basal BDNF levels. The 
average baseline BDNF levels for the CHO group were about 42 ng/mL while baseline 
BDNF levels were about 22 and 20 ng/mL for PLA and PRO group, respectively. A 
more plausible reason may be the exercise in days leading up to fixed intensity cycle. 
Exercise in PRO/PLA group was minimal compared to the intensified training of the 
CHO group, which provides a possible explanation for decreased baseline BDNF levels 
in the PLA/PRO group. Chronic endurance training is thought to increase basal BDNF 
levels, which may offer a potential link in the between-treatment differences seen with 
the PLA and CHO treatments (Zoladz et al, 2008). Higher training status and exercise 
leading up to 120-minute fixed-intensity trial are both associated with increased baseline 
BDNF levels, which may explain the increased baseline BDNF levels in the CHO group 
(Zoladz et al, 2008). BDNF levels typically stay elevated for at least 24 hours post-
exercise in chronic aerobic exercise, which would result in increased basal BDNF levels 
in CHO group, who continued “normal training” consisting of ≥ 7 hours of cycling a week 
for ≥ 2 months (including at least one ride ≥ 3 hours every 14 days) leading up to the 
120-minute fixed-intensity trial (Matthews et al, 2009; Schroer et al, 2014). Compared to 
the PRO/PLA group, who were instructed to avoid any heavy exercise 48 hours leading 
up to the exercise trial, BDNF response was likely elevated on the day of the fixed-
intensity trial, making it difficult to cross-reference to the PLA/PRO group. These 
increased baseline BDNF levels provide another possible explanation as to why BDNF 
response was ‘unclear’ in the CHO trials. 
	
19 
It is also worth noting that the BDNF response in the CHO group was associated 
with marked variability between subjects. Some subject’s experienced considerable 
decreases in BDNF while others experienced increases in BDNF. This suggests that 
other variables (i.e. training status, stress levels, sleep, recovery, genetics, etc.) could 
have influenced the BDNF change from pre to post-exercise as well. A major limitation 
of the current study is that we utilized data from two separate studies albeit with a nearly 
identical exercise protocol. Unfortunately, the two subject groups appeared to differ in 
training status therefore adding uncertainty to the results. Regardless, the current 
findings extend previous literature indicating that endurance exercise can increase 
BDNF levels (Seifert et al, 2010). Furthermore, PRO supplementation during the acute 
endurance exercise produces very similar results to that of the PLA. The most 
provocative finding was that CHO supplementation had an unclear effect on BDNF 
levels. These results should be reproduced using a within-subject design before 
definitive conclusions can be made. Interesting aspects of this study worth revisiting 
include the effect CHO supplementation has on this group and how BDNF response 
with CHO or PRO supplementation differs across varied training status’. The previously 
mentioned confounding variables notwithstanding, the mechanistic relationship between 
CHO supplementation and BDNF levels is unclear. The interrelationship between 
carbohydrate availability, substrate source utilization, and BDNF levels warrant further 
investigation, as BDNF seems to be a candidate novel biomarker of metabolic stress. 
Perhaps more importantly, though well beyond the scope of this project, and developing 
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